Saturday, December 10, 2016 A Member of the Neotrope® Interactive Network 
press release services
PRnetwire press release services 

Press Release Services from Send2Press
Recent Release Welcome Press Release Services Website Promotion PR/Web Reference Library portfolio


View Headlines

YOU ARE VIEWING CONTENT ON OUR LEGACY WEBSITE -- PLEASE GO TO OUR HOME PAGE TO LOCATE CURRENT AND UP TO DATE INFORMATION ABOUT OUR SERVICES, AND CURRENT CLIENT NEWS STORIES!


Send2Press™ Press Release Service
Get the word out to the media including trade and consumer magazines, TV, radio, and daily/weekly newspapers, about your business, product, or service starting at only $69!
Order a Press Release to promote your business!

Press Release Writing
We can help craft the perfect business announcement with our press release writing service!
Press Release Writing Services

DotComMojo™ Website Promotion
Make sure your website gets the attention it needs to succeed!
Submit your site to 3,500 search engines for as little as $19!


powered by neotrope hosting



Home > Recent Headlines > News Archive
 
PRnetwire™ News Article Archive

edited by Christopher Simmons, senior news editor

UNIVEC RECEIVES FDA 510(k) CLEARANCE FOR ITS NEW BIFURCATED SAFETY NEEDLE SPECIFICALLY DESIGNED FOR U.S. AND INTERNATIONAL SMALLPOX VACCINE PROGRAMS

 
NEWS WIRES:
» Ad Industry News
» Aerospace News
» Arts News
» Automobile News
» Biotech News
» Book News
» Business News
» Computer Industry News
» Construction News
» DotCom News
» eCommerce News
» Education News
» eMarketing News
» Entertainment News
» Employment News
» Energy News
» Family/Parenting News
» Fashion Industry News
» Fitness Industry News
» Food & Cooking News
» Graphics News
» Insurance News
» Interior Design News
» Internet News
» Investor News
» Manufacturing News
» Medical News
» Music News
» NonProfit News
» Peace/Ecology News
» Podcasting News
» Political News
» Real Estate News
» Religion News
» Retail News
» Security Solutions News
» Small Cap & OTC News
» Software Industry News
» Sports News
» Telecom News
» Travel Industry News
» TV & Cable News
» VoIP News
» US Newswires
» Business Profiles
» More News Channels
» Today's Headlines

Distribute your News with Send2Press® Press Release Services

 

FARMINGDALE, N.Y. -- (SEND2PRESS NEWSWIRE via PRNetwire) -- March 25, 2002 -- Farmingdale-based Univec, Inc., (OTCBB:UNVC - news) a leading manufacturer of patented auto-disable and safety syringes, distributor of physician samples and medical waste management technology, today announced FDA 510(k) clearance for its new Bifurcated Safety Needle. Univec's Bifurcated Safety Needle was specifically designed to meet the U.S. Government requirements for safe administration of the smallpox vaccine.

Univec's patented Bifurcated Safety Needles are the only bifurcated needles available that employ a sliding sheath mechanism that complies with the U.S. Needle Stick Law and OSHA regulations to effectively reduce the risk of accidental needle sticks.

According to Joel Schoenfeld, Univec's Chairman, and inventor of the Bifurcated Safety Needle, "Syringe and needle device manufactures have an obligation to the U.S. government and the people we serve, to offer safety devices that comply with the U.S. Needle Stick Law and OSHA requirements to protect patients and healthcare workers, and the new Univec Bifurcated Safety Needle does that."

This new device continues to add to the growth of products and services that Univec has in its pipeline of new products for safer health products to patients and caregivers worldwide.

About Univec
Founded in 1992, Univec is considered one of the leading innovators in the design and production of auto-disable and safety syringes, and with it's acquisition of Physician and Pharmaceutical Services, Inc. and Thermal Waste Technologies Inc., provides safe delivery of physician samples and disposal of infectious medical waste. The Company has production facilities in Portugal, South Korea, China, Belgium and the U.S., and has licensed its technology to Terumo of Belgium; a subsidiary of Terumo Japan, the leading producer of syringes outside the U.S. Univec distributes its products in 80 countries.

Forward Looking Statements
This document contains forward-looking statements based on current expectations that could be affected by the risks and uncertainties involved in Univec's business. These risks and uncertainties include, but are not limited to, the risks described from time to time in Univec's reports to the Securities and Exchange Commission, which include Univec's Annual Report on Form 10-K. Subsequent written or oral statements attributable to Univec or persons acting on its behalf are expressly qualified in their entirety by the cautionary statements in this document and those in Univec's reports filed with the SEC.

http://www.univec.com

MEDIA CONTACT
G. Edward Kalbaugh
Allegent Growth Strategies International
516-364-7034
gekalbaugh@allegentgsi.com

# # #

View the original news release in text-only format


 

EMAIL THIS NEWS ARTICLE TO SOMEONE
This news article was originally published on the PRnetwire™ (Send2Press.com)



Press Release Services from Send2Press

Top of Page | Home | Contact Us

Press Release Services | Website Promotion Services


Copyright 1983-2004 Neotrope® — all rights reserved. Neotrope, DotComMojo, PRnetwire, Send2Press, dot.Sorcerer, and Alchemy Positioning are trademarks of Neotrope, the company formerly known as Mindset (aka Mindset Netwire). Neotrope is a U.S. registered trademark.
www.Send2Press.com | www.DotComMojo.com

Website Powered by Neotrope® Hosting | Website Design by Neotrope®
Part of the Neotrope Interactive Network | Keyword Optimization by ContextEngine™
Page Last updated: Tuesday, November 01, 2016

PRnetwire is not responsible for accuracy of article content in the news article archive which is based on press release content that has been provided by the company or organization issuing the original news release.

NOTICE: THIS PAGE IS LEGACY ARCHIVAL CONTENT AND IS LIKELY NO LONGER VALID CONTENT.
For current news please see: http://www.send2press.com/newswire/